Home > Healthcare > Medical Devices > Therapeutic Devices > external defibrillators market
Get a free sample of External Defibrillators Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of External Defibrillators Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The rising prevalence of cardiac diseases is one of the major factors propelling the external defibrillators industry growth. Among these, tachycardia is one of the major precursors that promote the disease burden and inflict significant mortality rates. The increasing incidence & prevalence of this conditions, along with its sub-sets such as atrial fibrillation, ventricular tachycardia, supraventricular tachycardia (SVT), and ventricular fibrillation is set to drive the business trends.
Moreover, the rising prevalence of cardiac diseases with increasing age further fuels the risk of sudden cardiac arrest. As per the NCBI, the sudden cardiac arrest (SCA) rates surge with age, and the middle-aged adults (35–59 years) contributes to the higher proportion of SCA cases (30–40%). The use of defibrillators during an event of SCA plays a major role in reducing the complications and enhance the clinical outcome. Thus, the increasing incidence of cardiac ailments, in particular the SCA cases, rising number of hospitalizations, and geriatric population would drive the demand for external defibrillators, thereby augment the industry growth.
Abbott Laboratories, Inc., Boston Scientific Corporation, Koninklijke Philips, Stryker Corporation, Medtronic plc, LivaNova PLC, and Asahi Kasei Corporation (ZOLL Medical Corporation) are some of the major external defibrillator companies worldwide.
U.S. external defibrillator industry will register more than USD 2.1 billion in revenue by 2032 owing to presence of major industry players, the upsurge in demand for cardiovascular devices, and the rising prevalence of cardiovascular conditions in the region.
External defibrillator industry size was USD 3.2 billion in 2022 and will reach over USD 6.7 billion by 2032 due to rising prevalence of heart failure, increasing advancements in product technology, and surging incidence of sudden cardiac arrests worldwide.
Automated external defibrillator industry size will witness 7.5% CAGR from 2023-2032 on account of their increasing adoption to meet the surging prevalence of out-of-hospital cardiac arrest (OHCA).